Testosterone treatment study for men with chronic kidney disease
Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This Phase 2 study tests whether testosterone therapy can help men with chronic kidney disease who have low testosterone and related symptoms. It looks to see if treatment is safe and beneficial, while carefully checking heart, blood, prostate, and clotting risks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man age 18 to 85
- You have chronic kidney disease with kidney function in a specific range (eGFR 15–45)
- Your morning blood testosterone has been low (under 300 ng/dl) on two separate tests
- You have symptoms that can happen with low testosterone (like low libido, erections problems, fatigue, mood or sleep issues)
- Your iron levels are in a normal range (ferritin 100+ and iron saturation 20+)
- You have not used testosterone (or similar products like DHEA) in the last 6 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how testosterone therapy affects blood pressure over 24 hours in men with low testosterone. It may help you understand how this treatment could affect your heart health.
This study tests whether testosterone replacement therapy can safely improve low testosterone symptoms in men with low-risk prostate cancer who are under active surveillance. It aims to see if treatment can help without worsening the cancer.
This trial tests whether a special diet supplement (Ketoanalogue) can help protect your muscles while you follow a moderate protein diet. It is for people with chronic kidney disease stage 4 or 5 who are not on dialysis or have not had a kidney transplant.
This study tests whether a special diet can improve symptoms of low testosterone in men. It is intended to help men with certain symptoms like a low sex drive or trouble having erections and whose blood tests show low to borderline testosterone levels.
This trial tests a testosterone injection (XYOSTED) to see if it's safe and effective for replacing testosterone in teenage boys who have low levels due to a known medical condition. It lasts 52 weeks, with an optional 2-year follow-up.
This study looks at how a common prostate cancer treatment called androgen deprivation therapy (ADT) affects blood pressure and kidney function. It may help doctors understand and manage these side effects better.
Hear when a new Hypogonadism, Male trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.